PD-L1+ neutrophils decrease in patients recovering from severe disease, whereas IFN-active neutrophils appear in both mild and severe COVID-19 [208,209]; hence, their relevance to the disease process is currently unclear. The gene discussed is IFNA1; the disease is COVID-19.